Decision to Stop Contraceptive Injection
Sarah Watson, a 30-year-old mother of two, stopped using a contraceptive injection, Depo-Provera, after learning about its association with benign brain tumors. Weeks after discontinuation, Watson experienced severe health complications that required hospitalization.
Symptoms and Initial Misdiagnosis
Following her decision, Watson encountered unusual symptoms such as headaches, dizziness, and a sensation akin to a head rush. She shared, “I was sick three times and constantly felt tired.” Initially, her symptoms were misattributed to anxiety by her doctor, who prescribed medication. Despite this, Watson was convinced the symptoms had a different cause.
Her condition worsened, leading to a frightening incident where she collapsed at home, resulting in a head injury that required hospital care. A CT scan revealed no signs of severe conditions like meningioma, but Watson demanded further reassurance through an MRI scan.
Link Between Injection and Symptoms
Watson realized her symptoms might be linked to the recent cessation of the Depo-Provera injection. Her experience is supported by Dr. Julie Hammond, who explains that stopping the injection can cause hormone levels to fluctuate, affecting mood and energy. Ovulation may take up to a year to normalize, along with potential changes in menstrual cycles.
Dr. Hammond emphasized that women might genuinely experience symptoms during this transition period. “The symptoms are real and can be explained by physiological changes,” she stated.
Reasons for Stopping the Injection
Watson used Depo-Provera for over two years due to its convenience but decided to stop after learning of the risk of meningioma, as mentioned in safety updates from Pfizer. The injection is widely used, with the CDC reporting that 24.5% of sexually active women aged 15 to 49 have used it.
Following safety concerns, Pfizer updated warnings about the potential link between the injection and meningioma. They advise patients to seek medical help if they experience symptoms such as vision changes, worsening headaches, or seizures.
Pfizer’s Response
A spokesperson from Pfizer emphasized their commitment to patient safety. They assure continued monitoring of Depo-Provera’s safety profile and advise patients to consult healthcare professionals if they experience side effects.

Physicians Urge Senate to Reject FDA Nominee
Trump Issues Order to Combat Mosquito and Tick Populations
Experts Warn About Brain Health Risks with GLP-1 Weight-Loss Drugs
Gene Editing’s Ethical Dilemma and Potential
The Role of Home in Addressing Children’s Mental Health
Hurricane Polo Poses Flood Threat as It Approaches Southwestern U.S.